Trial Profile
Pilot Study of Interferon Alpha Lozenges Plus Oseltamivir in the Treatment of Influenza A Infection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary) ; Oseltamivir
- Indications Influenza A virus infections
- Focus Therapeutic Use
- Sponsors Ainos
- 07 Aug 2012 Planned end date changed from 1 Sep 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 07 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Jul 2011 Planned End Date changed from 1 Jul 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.